Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination

Background: High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particular...

Descripción completa

Detalles Bibliográficos
Autores: Hernaez, Alvaro, Soria-Florido, Maria Trinidad, Schroder, Helmut, Ros, Emilio, Pinto, Xavier, Estruch, Ramon, Salas-Salvado, Jordi, Corella, Dolores, Aros, Fernando, Serra-Majem, Lluis, Martinez-Gonzalez, Miguel Angel, Fiol Sala, Miquel, Lapetra, Jose, Elosua, Roberto, Lamuela-Raventos, Rosa María, Fito, Montserrat
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/22795
Acceso en línea:https://hdl.handle.net/20.500.12105/22795
Access Level:acceso abierto
Palabra clave:LDL-Colesterol
Femenino
Lipoproteínas HDL
HDL-Colesterol
Lipoproteínas LDL
Masculino
Aterosclerosis
Factores Sexuales
Estudios Transversales
Factores de Riesgo
Dislipidemias
Humanos
Persona de Mediana Edad
Factores de Edad
Anciano
Diabetes Mellitus Tipo 2
Enfermedades Cardiovasculares
Adulto
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Aged
Age Factors
Adult
Humans
Middle Aged
Cross-Sectional Studies
Lipoproteins, LDL
Male
Cholesterol, LDL
Lipoproteins, HDL
Sex Factors
Cholesterol, HDL
Dyslipidemias
Female
Risk Factors
Atherosclerosis
Descripción
Sumario:Background: High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particularly affected by different cardiovascular risk factors. Objective: To determine which lipoprotein properties are associated with greater cardiovascular risk scores and each cardiovascular risk factor. Methods: In two cross-sectional baseline samples of PREDIMED trial volunteers, we assessed the associations of HDL functionality (N = 296) and LDL atherogenicity traits (N = 210) with: 1) the 10-year predicted coronary risk (according to the Framingham-REGICOR score), and 2) classical cardiovascular risk factors. Results Greater cardiovascular risk scores were associated with low cholesterol efflux values; oxidized, triglyceride-rich, small HDL particles; and small LDLs with low resistance against oxidation (P-trend<0.05, all). After adjusting for the rest of risk factors; 1) type-2 diabetic individuals presented smaller and more oxidized LDLs (P<0.026, all); 2) dyslipidemic participants had smaller HDLs with an impaired capacity to metabolize cholesterol (P<0.035, all); 3) high body mass index values were associated to lower HDL and LDL size and a lower HDL capacity to esterify cholesterol (P<0.037, all); 4) men presented a greater HDL oxidation and lower HDL vasodilatory capacity (P<0.046, all); and 5) greater ages were related to small, oxidized, cytotoxic LDL particles (P<0.037, all). Conclusions: Dysfunctional HDL and atherogenic LDL particles are present in high cardiovascular risk patients. Dyslipidemia and male sex are predominantly linked to HDL dysfunctionality, whilst diabetes and advanced age are associated with LDL atherogenicity.